Galenica Sales Up 7.3% to CHF 1.41 Billion in First Four Months

Galenica Sales Up 7.3% in First Four Months

Galenica AG reported a 7.3% increase in sales to CHF 1,409.7 million for the first four months of 2026. The company achieved strong growth despite a challenging market environment.

Home Care and Diagnostics Segments Shine

Home care business sales rose 9.1% to CHF 41.9 million, while diagnostics contributed CHF 40.8 million. Performance in these segments supported overall growth.

2026 Guidance Maintained

Galenica confirmed its 2026 guidance for sales growth of 5%-7% and EBIT growth of 6%-8%. The company expects continued steady growth for the remainder of the year.